The Global Lactase Enzyme Market is expected to grow by $ 131.55 mn during 2021-2025 progressing at a CAGR of 4% during the forecast period

ReportLinker

Thu, Jan 28, 2021, 6:45 AM2 min read

Global Lactase Enzyme Market 2021-2025 The analyst has been monitoring the lactase enzyme market and it is poised to grow by $ 131. 55 mn during 2021-2025 progressing at a CAGR of 4% during the forecast period.

New York, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Lactase Enzyme Market 2021-2025" - https://www.reportlinker.com/p05618584/?utm_source=GNW
Our report on lactase enzyme market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven rising consumer focus on enzyme-based foods and growing collaborations increase the availability of lactose-free products. In addition, rising consumer focus on enzyme-based foods is anticipated to boost the growth of the market as well.
The lactase enzyme market analysis includes application segment and geographical landscapes.

The lactase enzyme market is segmented as below:
By Application
• Food and beverage
• Dietary supplements
• Pharmaceuticals

By Geographical Landscapes
• North America
• Europe
• APAC
• South America
• MEA

This study identifies increased technical advances in enzyme production as one of the prime reasons driving the lactase enzyme market growth during the next few years.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on lactase enzyme market covers the following areas:
• Lactase enzyme market sizing
• Lactase enzyme market forecast
• Lactase enzyme market industry analysis

Read the full report: https://www.reportlinker.com/p05618584/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

Berkshire's profit plunges 64% on portfolio holdings as Buffett sells Apple
Berkshire Hathaway's first quarter profits plummeted along with the paper value of its investments, but the company said Saturday that most of the businesses it owns outright performed well. The figures were heavily influenced by a large drop in the paper value of Berkshire’s investments. Buffett encourages investors to pay more attention to the conglomerate’s operating earnings that exclude the investment figures.
Associated Press Finance
This Dividend Stock Yields 4.4% and Has 15 Consecutive Years of Dividend Increases. Here's Why It's a Buy Now
This industry-leading company is out of favor and worth buying now.
Motley Fool
U.S. Money Supply Is Doing Something So Rare That It Hasn't Happened Since the Great Depression -- and a Big Move in Stocks May Follow
M2 money supply hasn't done this in nine decades.
Motley Fool
Berkshire shareholders reject climate, diversity, China proposals
Berkshire Hathaway Inc shareholders on Saturday overwhelmingly rejected six proposals addressing environmental and social policy issues at Warren Buffett's conglomerate, all of which the billionaire investor and his board opposed. By margins of more than 4-to-1, shareholders at Berkshire's annual meeting voted against two proposals that the company's insurance and energy operations disclose more about their efforts to address climate change including greenhouse gas emissions. They also turned down a proposal for more disclosure about efforts to promote diversity, equity and inclusion in the workplace.
Reuters
Here's the 1 Stock Warren Buffett Thinks Should Outperform the S&P 500 Without as Much Downside
A big cash pile protects the above-average core operations of this stellar company.
Motley Fool
Move Over, Nvidia: Billionaire Dan Loeb Is Betting on This Dividend-Paying Magnificent Seven Stock to Win the Artificial Intelligence (AI) Race Instead
Dan Loeb bet on one of the cheaper Magnificent Seven stocks as an underrated AI play.
Motley Fool
Should I Take a $48,000 Lump Sum or $462 Annuity From My Pension?
Buyout decisions have become increasingly common for those with a pension plan. If you get this offer, the most important questions to deal with include when you would you receive the payout, and how long you expect to live. The earlier you would receive a lump sum payout, the more it will be worth to you […] The post Should I Take a $48,000 Lump Sum or $462 Monthly Payments for a Pension Annuity? appeared first on SmartReads by SmartAsset.
SmartAsset
Warren Buffett says Berkshire sold entire Paramount stake at a loss
NEW YORK (Reuters) -Warren Buffett said on Saturday that Berkshire Hathaway sold its entire holding in media and entertainment company Paramount Global at a loss and he took sole responsibility for the decision. "It was 100% my decision, and we've sold it all, and we lost quite a bit of money," Buffett said at Berkshire's annual shareholder meeting in Omaha, Nebraska. Berkshire held 63.3 million Paramount Class B shares at the end of 2023 or about 10.1% of the company.
Reuters
Bank of America Throws Its Weight Behind These 2 ‘Strong Buy’ Stocks
We’ve received some mixed messages from the market recently. The S&P 500 finished April with a 4% loss, its first monthly loss after five straight months of gains. But the month of May has started with gains in trading, and the earnings season for 1Q24 has turned out better than expected. In addition, the Federal Reserve has indicated that it will be keeping interest rates ‘higher for longer,’ while inflation remains stubborn. A rate cut this year is still considered possible, but not likely unt
TipRanks
This Billionaire Is Selling This Magnificent Dividend Stock: Here Are 3 Other Higher-Yielding Dividend Stocks He Likes Instead
Bill Gross thinks a few other MLPs are more attractive than Enterprise Products Partners right now.
Motley Fool

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

The Global Lactase Enzyme Market is expected to grow by $ 131.55 mn during 2021-2025 progressing at a CAGR of 4% during the forecast period

Recommended Stories

Berkshire's profit plunges 64% on portfolio holdings as Buffett sells Apple

This Dividend Stock Yields 4.4% and Has 15 Consecutive Years of Dividend Increases. Here's Why It's a Buy Now

U.S. Money Supply Is Doing Something So Rare That It Hasn't Happened Since the Great Depression -- and a Big Move in Stocks May Follow

Berkshire shareholders reject climate, diversity, China proposals

Here's the 1 Stock Warren Buffett Thinks Should Outperform the S&P 500 Without as Much Downside

Move Over, Nvidia: Billionaire Dan Loeb Is Betting on This Dividend-Paying Magnificent Seven Stock to Win the Artificial Intelligence (AI) Race Instead

Should I Take a $48,000 Lump Sum or $462 Annuity From My Pension?

Warren Buffett says Berkshire sold entire Paramount stake at a loss

Bank of America Throws Its Weight Behind These 2 ‘Strong Buy’ Stocks

This Billionaire Is Selling This Magnificent Dividend Stock: Here Are 3 Other Higher-Yielding Dividend Stocks He Likes Instead